ArticleEuropean journal of nutrition2025
Correlates of serum holo-Transcobalamin in the elderly general population.
Article in European journal of nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHolo-Transcobalamin (holo-TC) is the biologically active form of vitamin B12, an essential vitamin that is only contained in animal derived food products. While severe vitamin B12 deficiency has well known clinical consequences, the relation of holo-TC within the physiological range to various metabolic and lifestyle parameters in the general population is largely unknown.
objectiveWe aimed to identify cross-sectional metabolic, lifestyle, and dietary correlates of serum holo-TC in a population-based sample.
methodsSerum holo-TC was measured by electro-chemiluminescence in n = 788 individuals (44.0% females, age 61.3 [52.8; 70.2] years). Significant metabolic and lifestyle correlates of serum holo-TC were identified in a backward selection process and included in a final linear regression model. We used a validated Food Frequency Questionnaire to determine daily dietary intake of dairy products, eggs, fish and seafood, and meat and meat products. Associations of food group intake with holo-TC were tested in multivariable-adjusted analyses, both continuously by linear regression models and across holo-TC tertiles by ANCOVA.
resultsMedian serum holo-TC was measured at 83.6 [66.9; 115.2] pmol/L. We identified a 10% increase in alanine aminotransferase, total cholesterol, diastolic blood pressure, or alcohol consumption to confer a 2.03% [1.46; 2.60], 4.58% [1.79; 7.45], -2.66% [-4.78; -0.48], or -0.25% [-0.45; -0.05] change in serum holo-TC, respectively. Compared to no supplementation, vitamin B complex supplementation conferred 19.59% [9.72; 30.34] and females compared to males showed 11.55% [5.38; 18.08] higher serum holo-TC levels. Furthermore, a higher consumption of dairy products (in males and females) and fish and seafood (in males) was associated with significantly higher levels of serum holo-TC.
conclusionsVitamin B complex supplementation, dairy products and fish and seafood were identified as major sources of vitamin B12 uptake being reflected in serum holo-TC. Furthermore, sex, total cholesterol, a biomarker of liver function, diastolic blood pressure, and alcohol consumption were associated with serum holo-TC in the northern German population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.